GlassScriptPhysician profile
Rosner P Luss
NPI 1144270349
$1,168.77
in general payments reported to CMS, 2019-2025
14 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $12.03 · 2021: $184 · 2022: $247 · 2023: $121 · 2024: $114 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $323.17 | 2021-2025 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $226.63 | 2022-2025 | |
| Exact Sciences Corporation | $116.82 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $108.62 | 2022-2025 | |
| Lilly USA, LLC | $99.98 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $88.65 | 2019-2021 | |
| Novo Nordisk INC | $74.02 | 2019-2023 | Ozempic, Rybelsus |
| Jazz Pharmaceuticals INC. | $31.18 | 2025 | |
| Abbott Laboratories | $28.19 | 2021 | |
| Amarin Pharma, INC. | $19.26 | 2021 | |
| Strongbridge US INC. | $15.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.87 | 2019 | |
| Allergan, INC. | $12.03 | 2020 | |
| Vanda Pharmaceuticals INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosner Luss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.